Jagsonpal Pharma fixes Sep 4 record date for Rs. 4 dividend

Corporate Actions View source PDF Explain this filing

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.1%Reaction day

₹230.00

prior close

₹238.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%+1.7% vs market

Pharmaceuticals peers, median of 162sector-0.8%+1.9% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+8.3

10m

+6.8

15m

+9.5

30m

+6.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.1-0.6+1.7-0.8+1.9

Next day

+0.1+0.5-0.4-0.5+0.6

+2.6+1.9+0.8+0.2+2.4

+2.6+2.3+0.3+0.1+2.5

+4.3+3.6+0.7+0.5+3.9

+3.0+4.0-0.9+0.4+2.6

+1.7+4.0-2.2+1.4+0.3

15d

+1.2+4.9-3.6+0.3+0.9

+4.9+5.9-1.0+1.6+3.3

+3.2+4.8-1.6+2.7+0.5

-6.5pendingpending-2.4-4.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 162Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jagsonpal Pharmaceuticals has fixed September 4, 2026 as the record date to determine shareholders eligible for dividend, subject to AGM approval. The Board had earlier recommended a dividend of Rs. 4 per equity share (200 percent) on face value of Rs. 2 for FY ending March 31, 2026. The 47th AGM will be held on September 18, 2026 via video conferencing. If approved, dividend will be paid within 30 days, after applicable tax deduction.

Likely market impact

Shareholders holding stock by Sep 4 record date will be eligible for Rs. 4 dividend per share, pending AGM approval on Sep 18.